Phase IIIMitochondrial Peptide
Compound 61676
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061676
Risk Class
HIGH
Last Audit
Jun 7, 2108
Research Abstract
Mitochondrial Peptide candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Compound 61676 is a mitochondrial peptide asset inside mitochondrial peptide innovation track initiatives, optimized for cognitive resilience and neuroprotection.
The dossier currently sits in phase iii with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061676 with updates logged 2108-06-07.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cognitive resilienceNeuroprotection
Nomenclature
CX-61676Mitochondrial Peptide Program 61676
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061676
- [2] Operations Pulse • Mitochondrial Peptide innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61676